Valion Bio, Inc.
USD0.51
+0.02 (+3.40%)
CEO
Michael R. Cavanaugh
IPO Date
2021-11-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.45
Prev. Close
$0.49
Day Low
$0.43
Day High
$0.51
52W Low
$0.40
52W High
$5.60
Market Cap
$0.00B
Volume
0.31M
| 92 |
| $0.00 |
| 20 May 2026 | Handley Michael K | director, officer: Chief Executive Officer | M-Exempt | Acquired | 2,206 | $0.00 |
| 20 May 2026 | Handley Michael K | director, officer: Chief Executive Officer | M-Exempt | Disposed | 2,206 | $0.00 |
| 4 May 2026 | Lackey Melinda | General Counsel & SVP of Legal | A-Award | Acquired | 45,000 | $0.96 |
| 4 May 2026 | Lackey Melinda | officer | Disposed | 0 | $0.00 |
| 26 Aug 2021 | LoConti Joseph E. | 10 percent owner | P-Purchase | Acquired | 1,000 | $0.20 |
| 26 Aug 2021 | LoConti Joseph E. | 10 percent owner | P-Purchase | Acquired | 13,000 | $0.20 |
| 26 Aug 2021 | LoConti Joseph E. | 10 percent owner | P-Purchase | Acquired | 20,000 | $0.20 |
| 26 Aug 2021 | LoConti Joseph E. | 10 percent owner | P-Purchase | Acquired | 67,000 | $0.19 |